Oregon Zoo Elephant Tula-Tu Recovering From Potentially Deadly Virus

PORTLAND, OR – A young Asian elephant at the Oregon Zoo has made it through the worst of a life-threatening viral infection and appears to be on track for a full recovery, zoo officials said.
Tula-Tu no longer requires treatment after a two-week battle with elephant endotheliotropic herpesvirus, or EEHV, according to the zoo.
“At last, we can say she is out of the woods,” said Carlos Sanchez, the zoo’s director of animal health. “Her white-cell counts are normal, and her viral load continues to decrease. She’s been eating well, running around and looking like her usual self.”
Since her diagnosis two weeks ago, Tula-Tu has received antiviral medications, fluids and a series of plasma transfusions. While she still tests positive for the virus — which could take weeks to fully clear — care staff have stopped active treatments and will instead monitor her appetite, behavior, white-cell count and viral load.
“Tula’s recovery owes everything to the incredible care she’s received and the power of teamwork and careful planning,” Sanchez said. “We’re just going to step aside and let her get back to being a joyful little elephant.”
Steve Lefave, who oversees the zoo’s elephant area, praised the care team’s efforts during the difficult fight, saying there was never any doubt they would give her every chance to survive.
Fast turnaround times on blood tests aided the treatment process. Through a partnership with the molecular lab at the Oregon Veterinary Diagnostic Laboratory at Oregon State University, staff can collect blood samples in the morning and receive results by the afternoon, Sanchez said.
Justin Sanders, head of the lab’s molecular diagnostics section, noted that the partnership provides a direct connection between laboratory testing and immediate clinical interventions for the patient.
According to Sanchez, who chairs the North American EEHV Advisory Group Research Committee, EEHV is a latent virus present in nearly all Asian elephants in the wild and in human care. While most elephants develop natural immunity, calves become highly vulnerable between ages 1 and 8 as their maternal antibodies decline.
Once active, the virus can become fatal within days. Another calf born to Tula-Tu’s mother, Rose-Tu, died from the disease in 2018 just before her sixth birthday. However, Sanchez said advancements in early detection, vaccines and transfusion protocols have significantly improved survival rates.
Earlier this year, Tula-Tu became the first elephant on the West Coast to receive an mRNA vaccine targeting EEHV-1A, the virus’s most common strain. Her recent illness was caused by a related strain, EEHV-1B, which accounts for fewer reported fatal infections than EEHV-1A but can still cause severe disease in young Asian elephants.